Jaguar Health, Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q3 2016 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Jaguar Health, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q3 2016 to Q2 2025.
- Jaguar Health, Inc. Earnings Per Share, Diluted for the quarter ending June 30, 2025 was -10.3 USD/shares, a 286% decline year-over-year.
- Jaguar Health, Inc. Earnings Per Share, Diluted for the twelve months ending June 30, 2025 was -67 USD/shares, a 97.5% increase year-over-year.
- Jaguar Health, Inc. annual Earnings Per Share, Diluted for 2024 was -131 USD/shares, a 95.1% increase from 2023.
- Jaguar Health, Inc. annual Earnings Per Share, Diluted for 2023 was -2.68K USD/shares, a 7302% decline from 2022.
- Jaguar Health, Inc. annual Earnings Per Share, Diluted for 2022 was -36.2 USD/shares, a 59% increase from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)